West Nile Virus Cases Surge in Austria, New Variant Detected
A concerning rise in West Nile virus (WNV) infections, coupled with the emergence of a novel viral strain, is prompting alarm among health officials in Austria. Researchers report a record number of cases in 2024, signaling the virus is now firmly established within the country’s ecosystem.
Record Infections and a Growing Threat
Austria is experiencing a significant escalation in West Nile virus activity. A recent long-term study conducted by the Medical University of Vienna in collaboration with AGES, analyzing data from 2009 to 2024, revealed that 2024 saw the highest number of confirmed infections since the virus was first detected in the country. A total of 37 confirmed cases were recorded, with 19 patients requiring hospitalization due to severe illness.
“More infections than ever before since the first detection in 2009,” stated a leading researcher involved in the study. “The significant increase in cases shows that the West Nile virus is now firmly established in Austria.”
Northern Burgenland Identified as a Hotspot
The northern region of Burgenland is emerging as a particular hotspot for the virus. The spread of WNV in this area has been notably more pronounced than in previous years. Adding to the concern, researchers have identified a new virus variant in Burgenland, one previously prevalent in southern and southeastern Europe.
“The fact that we are observing new regional priorities underlines the need to be vigilant in areas that have previously been less affected,” emphasized a professor of viral immunology at the Medical University of Vienna. Medical professionals are being urged to consider WNV as a potential diagnosis, even in patients without a history of travel, particularly during the summer months when symptoms like meningitis or encephalitis present.
Silent Spread and Limited Protection
The actual number of West Nile virus infections is likely far higher than reported, as approximately 80% of those infected experience no symptoms. Around 20% develop flu-like symptoms – including fever, headaches, and body aches – while less than 1% experience severe neurological complications such as encephalitis or meningitis.
Currently, there is no vaccine available for humans to prevent West Nile virus infection. Prevention relies heavily on personal protective measures, including the use of insect repellent, wearing protective clothing, and eliminating standing water where mosquitoes can breed.
European Expansion of a Tropical Disease
Originally isolated in Uganda in 1937, the West Nile virus has been circulating in Europe since the early 2000s. It is now considered endemic in many European countries, with significant outbreaks previously reported in southern and southeastern Europe. Italy experienced fatalities linked to WNV infection last summer, and Germany’s Robert Koch Institute (RKI) has registered cases since 2019.
The RKI forecasts that WNV will continue to establish itself within Germany, indicating a broader trend of the virus expanding its reach across the continent. The evolving situation underscores the need for continued surveillance and proactive public health measures to mitigate the impact of this growing threat.
(Sources: Medical University of Vienna, Eurosurveillance study, RKI, AGES)
